{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:06:02Z","timestamp":1793048762834,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,11,27]],"date-time":"2013-11-27T00:00:00Z","timestamp":1385510400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1007\/s00277-013-1964-1","type":"journal-article","created":{"date-parts":[[2013,11,26]],"date-time":"2013-11-26T10:50:34Z","timestamp":1385463034000},"page":"81-88","source":"Crossref","is-referenced-by-count":126,"title":["The KIT D816V expressed allele burden for diagnosis and disease monitoring of systemic mastocytosis"],"prefix":"10.1007","volume":"93","author":[{"given":"Philipp","family":"Erben","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Schwaab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Metzgeroth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Peter","family":"Horny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Jawhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Sotlar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Fabarius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Teichmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin C.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Giehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Marx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Hochhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolf-Karsten","family":"Hofmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas C. P.","family":"Cross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Reiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,11,27]]},"reference":[{"key":"1964_CR1","doi-asserted-by":"crossref","unstructured":"Valent P, Horny HP, Escribano L, Longley BJ, Li CY, Schwartz LB et al (2001 Jul) Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res 25(7):603\u2013625","DOI":"10.1016\/S0145-2126(01)00038-8"},{"issue":"2","key":"1964_CR2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000101711","volume":"74","author":"HP Horny","year":"2007","unstructured":"Horny HP, Sotlar K, Valent P (2007) Mastocytosis: state of the art. Pathobiology 74(2):121\u2013132","journal-title":"Pathobiology"},{"key":"1964_CR3","first-page":"291","volume-title":"Pathology and genetics: tumours of haematopoietic and lymphoid tissues: World Health Organization (WHO) Classification of Tumours, vol 1","author":"P Valent","year":"2001","unstructured":"Valent P, Akin C, Longley JB, Metcalfe DD, Parwaresch RM, Bennett JM (2001) Mastocytosis. In: Jaffe ES, NLH HS, Vardiman JW (eds) Pathology and genetics: tumours of haematopoietic and lymphoid tissues: World Health Organization (WHO) Classification of Tumours, vol 1. IARC, Lyon, pp 291\u2013302"},{"key":"1964_CR4","doi-asserted-by":"crossref","unstructured":"Horny HP, Valent P (2001 Jul) Diagnosis of mastocytosis: general histopathological aspects, morphological criteria, and immunohistochemical findings. Leuk Res 25(7):543\u2013551","DOI":"10.1016\/S0145-2126(01)00021-2"},{"key":"1964_CR5","doi-asserted-by":"crossref","unstructured":"Tefferi A, Thiele J, Vardiman JW (2009 Sep 1) The 2008 World Health Organization classification system for myeloproliferative neoplasms: order out of chaos. Cancer 115(17):3842\u20133847","DOI":"10.1002\/cncr.24440"},{"key":"1964_CR6","doi-asserted-by":"crossref","unstructured":"Valent P, Arock M, Akin C, Sperr WR, Reiter A, Sotlar K et al (2010 Aug 5) The classification of systemic mastocytosis should include mast cell leukemia (MCL) and systemic mastocytosis with a clonal hematologic non-mast cell lineage disease (SM-AHNMD). Blood 116(5):850\u2013851","DOI":"10.1182\/blood-2010-05-285270"},{"key":"1964_CR7","doi-asserted-by":"crossref","unstructured":"Vardiman JW (2010 Mar 19) The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues: an overview with emphasis on the myeloid neoplasms. Chem Biol Interact 184(1\u20132):16\u201320","DOI":"10.1016\/j.cbi.2009.10.009"},{"key":"1964_CR8","doi-asserted-by":"crossref","unstructured":"Pardanani A (2012 Apr) Systemic mastocytosis in adults: 2012 Update on diagnosis, risk stratification, and management. Am J Hematol 87(4):401\u2013411","DOI":"10.1002\/ajh.23134"},{"key":"1964_CR9","doi-asserted-by":"crossref","unstructured":"Schittenhelm MM, Shiraga S, Schroeder A, Corbin AS, Griffith D, Lee FY et al (2006 Jan 1) Dasatinib (BMS-354825), a dual SRC\/ABL kinase inhibitor, inhibits the kinase activity of wild-type, juxtamembrane, and activation loop mutant KIT isoforms associated with human malignancies. Cancer Res 66(1):473\u2013481","DOI":"10.1158\/0008-5472.CAN-05-2050"},{"key":"1964_CR10","doi-asserted-by":"crossref","unstructured":"Valent P, Akin C, Sperr WR, Mayerhofer M, Fodinger M, Fritsche-Polanz R et al (2005 Jan) Mastocytosis: pathology, genetics, and current options for therapy. Leuk Lymphoma 46(1):35\u201348","DOI":"10.1080\/10428190400010775"},{"key":"1964_CR11","doi-asserted-by":"crossref","unstructured":"Garcia-Montero AC, Jara-Acevedo M, Teodosio C, Sanchez ML, Nunez R, Prados A et al (2006 Oct 1) KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients. Blood 108(7):2366\u20132372","DOI":"10.1182\/blood-2006-04-015545"},{"key":"1964_CR12","doi-asserted-by":"crossref","unstructured":"Valent P, Akin C, Escribano L, Fodinger M, Hartmann K, Brockow K et al (2007 Jun) Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Invest 37(6):435\u2013453","DOI":"10.1111\/j.1365-2362.2007.01807.x"},{"key":"1964_CR13","doi-asserted-by":"crossref","unstructured":"Akin C, Metcalfe DD (2004 Jul) The biology of Kit in disease and the application of pharmacogenetics. J Allergy Clin Immunol 114(1):13\u201319, quiz 20","DOI":"10.1016\/j.jaci.2004.04.046"},{"key":"1964_CR14","doi-asserted-by":"crossref","unstructured":"Pardanani A, Reeder T, Li CY, Tefferi A (2003 Oct) Eosinophils are derived from the neoplastic clone in patients with systemic mastocytosis and eosinophilia. Leuk Res 27(10):883\u2013885","DOI":"10.1016\/S0145-2126(03)00065-1"},{"key":"1964_CR15","doi-asserted-by":"crossref","unstructured":"Taylor ML, Sehgal D, Raffeld M, Obiakor H, Akin C, Mage RG et al (2004 Nov) Demonstration that mast cells, T cells, and B cells bearing the activating kit mutation D816V occur in clusters within the marrow of patients with mastocytosis. J Mol Diagn 6(4):335\u2013342","DOI":"10.1016\/S1525-1578(10)60529-6"},{"key":"1964_CR16","doi-asserted-by":"crossref","unstructured":"Yavuz AS, Lipsky PE, Yavuz S, Metcalfe DD, Akin C (2002 Jul 15) Evidence for the involvement of a hematopoietic progenitor cell in systemic mastocytosis from single-cell analysis of mutations in the c-kit gene. Blood 100(2):661\u2013665","DOI":"10.1182\/blood-2002-01-0203"},{"key":"1964_CR17","doi-asserted-by":"crossref","unstructured":"Butterfield JH, Weiler D, Dewald G, Gleich GJ (1988) Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk Res 12(4):345\u2013355","DOI":"10.1016\/0145-2126(88)90050-1"},{"key":"1964_CR18","doi-asserted-by":"crossref","unstructured":"Cross NC, Hughes TP, Feng L, O'Shea P, Bungey J, Marks DI et al (1993 May) Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: correlations with acute graft-versus-host disease and relapse. Br J Haematol 84(1):67\u201374","DOI":"10.1111\/j.1365-2141.1993.tb03026.x"},{"key":"1964_CR19","doi-asserted-by":"crossref","unstructured":"Muller MC, Erben P, Saglio G, Gottardi E, Nyvold CG, Schenk T et al (2008 Jan) Harmonization of BCR-ABL mRNA quantification using a uniform multifunctional control plasmid in 37 international laboratories. Leukemia 22(1):96\u2013102","DOI":"10.1038\/sj.leu.2404983"},{"key":"1964_CR20","doi-asserted-by":"crossref","unstructured":"Kristensen T, Vestergaard H, Moller MB (2011 Mar) Improved detection of the KIT D816V mutation in patients with systemic mastocytosis using a quantitative and highly sensitive real-time qPCR assay. J Mol Diagn 13(2):180\u2013188","DOI":"10.1016\/j.jmoldx.2010.10.004"},{"key":"1964_CR21","doi-asserted-by":"crossref","unstructured":"Schwaab J, Schnittger S, Sotlar K, Walz C, Fabarius A (2013 Aug 19) Pfirrmann M, et al. Comprehensive mutational profiling in advanced systemic mastocytosis, Blood","DOI":"10.1182\/blood-2013-04-496448"},{"issue":"8","key":"1964_CR22","doi-asserted-by":"crossref","first-page":"e43090","DOI":"10.1371\/journal.pone.0043090","volume":"7","author":"F Traina","year":"2012","unstructured":"Traina F, Visconte V, Jankowska AM, Makishima H, O'Keefe CL, Elson P et al (2012) Single nucleotide polymorphism array lesions, TET2, DNMT3A, ASXL1 and CBL mutations are present in systemic mastocytosis. PLoS One 7(8):e43090","journal-title":"PLoS One"},{"key":"1964_CR23","doi-asserted-by":"crossref","unstructured":"Corless CL, Harrell P, Lacouture M, Bainbridge T, Le C, Gatter K et al (2006 Nov) Allele-specific polymerase chain reaction for the imatinib-resistant KIT D816V and D816F mutations in mastocytosis and acute myelogenous leukemia. J Mol Diagn 8(5):604\u2013612","DOI":"10.2353\/jmoldx.2006.060089"},{"key":"1964_CR24","doi-asserted-by":"crossref","unstructured":"Lippert E, Boissinot M, Kralovics R, Girodon F, Dobo I, Praloran V et al (2006 Sep 15) The JAK2-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera. Blood 108(6):1865\u20131867","DOI":"10.1182\/blood-2006-01-013540"},{"key":"1964_CR25","doi-asserted-by":"crossref","unstructured":"Galli SJ (2000 Jan) Mast cells and basophils. Curr Opin Hematol 7(1):32\u201339","DOI":"10.1097\/00062752-200001000-00007"},{"key":"1964_CR26","unstructured":"Galli SJ (1990 Jan) New insights into \u201cthe riddle of the mast cells\u201d: microenvironmental regulation of mast cell development and phenotypic heterogeneity. Lab Invest 62(1):5\u201333"},{"key":"1964_CR27","doi-asserted-by":"crossref","unstructured":"Tan A, Westerman D, McArthur GA, Lynch K, Waring P, Dobrovic A (2006 Dec) Sensitive detection of KIT D816V in patients with mastocytosis. Clin Chem 52(12):2250\u20132257","DOI":"10.1373\/clinchem.2006.068205"},{"key":"1964_CR28","doi-asserted-by":"crossref","unstructured":"Schumacher JA, Elenitoba-Johnson KS, Lim MS (2008 Jan) Detection of the c-kit D816V mutation in systemic mastocytosis by allele-specific PCR. J Clin Pathol 61(1):109\u2013114","DOI":"10.1136\/jcp.2007.047928"},{"key":"1964_CR29","doi-asserted-by":"crossref","unstructured":"Kristensen T, Broesby-Olsen S, Vestergaard H, Bindslev-Jensen C, Moller MB (2012 Jul) Circulating KIT D816V mutation-positive non-mast cells in peripheral blood are characteristic of indolent systemic mastocytosis. Eur J Haematol 89(1):42\u201346","DOI":"10.1111\/j.1600-0609.2012.01789.x"},{"key":"1964_CR30","doi-asserted-by":"crossref","unstructured":"Teodosio C, Garcia-Montero AC, Jara-Acevedo M, Alvarez-Twose I, Sanchez-Munoz L, Almeida J et al (2012 May) An immature immunophenotype of bone marrow mast cells predicts for multilineage D816V KIT mutation in systemic mastocytosis. Leukemia 26(5):951\u2013958","DOI":"10.1038\/leu.2011.293"},{"key":"1964_CR31","doi-asserted-by":"crossref","unstructured":"Noack F, Escribano L, Sotlar K, Nunez R, Schuetze K, Valent P et al (2003 Feb) Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL. Leuk Lymphoma 44(2):313\u2013319","DOI":"10.1080\/1042819021000037967"},{"key":"1964_CR32","doi-asserted-by":"crossref","unstructured":"Sotlar K, Fridrich C, Mall A, Jaussi R, Bultmann B, Valent P et al (2002 Nov) Detection of c-kit point mutation Asp-816 \u2013\u2009>\u2009Val in microdissected pooled single mast cells and leukemic cells in a patient with systemic mastocytosis and concomitant chronic myelomonocytic leukemia. Leuk Res 26(11):979\u2013984","DOI":"10.1016\/S0145-2126(02)00041-3"},{"key":"1964_CR33","doi-asserted-by":"crossref","unstructured":"Valent P, Akin C, Sperr WR, Horny HP, Metcalfe DD (2002 Feb) Smouldering mastocytosis: a novel subtype of systemic mastocytosis with slow progression. Int Arch Allergy Immunol 127(2):137\u2013139","DOI":"10.1159\/000048185"},{"key":"1964_CR34","doi-asserted-by":"crossref","unstructured":"Sotlar K, Colak S, Bache A, Berezowska S, Krokowski M, Bultmann B et al (2010 Apr) Variable presence of KITD816V in clonal haematological non-mast cell lineage diseases associated with systemic mastocytosis (SM-AHNMD). J Pathol 220(5):586\u2013595","DOI":"10.1002\/path.2677"},{"issue":"1","key":"1964_CR35","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000085563","volume":"114","author":"C Akin","year":"2005","unstructured":"Akin C (2005) Clonality and molecular pathogenesis of mastocytosis. Acta Haematol 114(1):61\u201369","journal-title":"Acta Haematol"},{"key":"1964_CR36","doi-asserted-by":"crossref","unstructured":"Georgin-Lavialle S, Lhermitte L, Baude C, Barete S, Bruneau J, Launay JM et al (2011 Nov 10) Blood CD34-c-Kit\u2009+\u2009cell rate correlates with aggressive forms of systemic mastocytosis and behaves like a mast cell precursor. Blood 118(19):5246\u20135249","DOI":"10.1182\/blood-2011-02-335950"},{"key":"1964_CR37","doi-asserted-by":"crossref","unstructured":"Emig M, Saussele S, Wittor H, Weisser A, Reiter A, Willer A et al (1999 Nov) Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR. Leukemia 13(11):1825\u20131832","DOI":"10.1038\/sj.leu.2401566"},{"issue":"3","key":"1964_CR38","first-page":"169","volume":"67","author":"J Cools","year":"2005","unstructured":"Cools J (2005) FIP1L1-PDGFR alpha, a therapeutic target for the treatment of chronic eosinophilic leukemia. Verh K Acad Geneeskd Belg 67(3):169\u2013176","journal-title":"Verh K Acad Geneeskd Belg"},{"key":"1964_CR39","doi-asserted-by":"crossref","unstructured":"Erben P, Gosenca D, Muller MC, Reinhard J, Score J, Del Valle F et al (2010 May) Screening for diverse PDGFRA or PDGFRB fusion genes is facilitated by generic quantitative reverse transcriptase polymerase chain reaction analysis. Haematologica 95(5):738\u2013744","DOI":"10.3324\/haematol.2009.016345"},{"key":"1964_CR40","doi-asserted-by":"crossref","unstructured":"Pardanani A, Tefferi A (2010 May) A critical reappraisal of treatment response criteria in systemic mastocytosis and a proposal for revisions. Eur J Haematol 84(5):371\u2013378","DOI":"10.1111\/j.1600-0609.2010.01407.x"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-013-1964-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-013-1964-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-013-1964-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,4]],"date-time":"2019-08-04T03:03:22Z","timestamp":1564887802000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-013-1964-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,27]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["1964"],"URL":"https:\/\/doi.org\/10.1007\/s00277-013-1964-1","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,27]]}}}